Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI ranks Cooper Companies, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Cooper Companies, Inc. is a large-cap company with a market capitalization of $10.38B. It ranks number 2 by market capitalization among the 8 Ophthalmic Goods issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for COO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, COO included.
Follow COO free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Ophthalmic Goods peers listed below that report each metric.
| Metric | COO | Rank |
|---|---|---|
| Market Cap | $10.38B | 2/8 |
| P/E Ratio | 18.20x | – |
| P/B Ratio | 1.25x | 4/7 |
| EPS | $3.62 | – |
| Book Value/Share | $43.80 | – |
| Revenue/Share | $22.28 | – |
| FCF/Share | $3.57 | – |
| Metric | COO | Rank |
|---|---|---|
| ROE | 6.8% | – |
| ROA | 4.5% | – |
| ROIC | 5.0% | 2/6 |
| Gross Margin | 65.9% | 3/6 |
| Operating Margin | 12.8% | 1/6 |
| Net Margin | 13.5% | – |
| EBT Margin | 10.9% | 1/6 |
| Tax Rate | -23.3% | – |
| Metric | COO | Rank |
|---|---|---|
| Current Ratio | 1.22x | 6/7 |
| Quick Ratio | 0.73x | 6/7 |
| D/E Ratio | 0.52x | 4/7 |
| Financial Leverage | 1.52x | 4/7 |
| Interest Coverage | 1.2x | 4/6 |
| Working Capital | $415M | 2/7 |
| Metric | COO | Rank |
|---|---|---|
| Operating Cash Flow | $1.03B | 2/8 |
| Free Cash Flow | $678M | 1/6 |
| Capital Spending | -$355M | 6/6 |
| OCF Growth YoY | 26.6% | – |
| FCF Growth YoY | 64.6% | – |
| FCF/Sales | 16.0% | 1/6 |
| CapEx/Sales | 8.4% | 1/6 |
| Metric | COO | Rank |
|---|---|---|
| Asset Turnover | 0.33x | 7/7 |
| Receivables Turnover | 5.4x | 5/7 |
| Inventory Turnover | 1.6x | 5/6 |
| Fixed Assets Turnover | 2.0x | 7/7 |
| Days Sales Outstanding | 68 days | 3/7 |
| Days Inventory | 230 days | 2/6 |
| Payables Period | 64 days | 2/5 |
| Cash Conversion Cycle | 235 days | 2/5 |
| Metric | COO | Rank |
|---|---|---|
| Total Revenue | $4.24B | 2/7 |
| Operating Income | $544M | 2/7 |
| Net Income | $570M | – |
| R&D Expense | $170M | 3/6 |
| SG&A Expense | $1.89B | 2/7 |
| Cost of Goods Sold | $1.44B | 2/7 |
| Metric | COO | Rank |
|---|---|---|
| Shares Outstanding | 190M | – |
| Total Current Assets | $2.28B | 18.0% of assets |
| Cash & Short-term Investments | $155M | 1.2% of assets |
| Accounts Receivable | $789M | 6.2% of assets |
| Inventory | $912M | 7.2% of assets |
| Total Liabilities | $4.34B | 34.3% of assets |
| Short-term Debt | $1.62B | 12.7% of assets |
Companies classified under the same SEC industry code as Cooper Companies, Inc. (Ophthalmic Goods): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| COO Cooper Companies, Inc. | ▼ | $10.38B |
| ALC Alcon Inc | ▼ | $30.71B |
| BLCO Bausch & Lomb Corp | ▶ | $5.65B |
| WRBY Warby Parker Inc. | ▲ | $3.28B |
| EYE National Vision Holdings, Inc. | ▼ | $1.35B |
| STAA Staar Surgical Co | ▶ | $1.08B |
| RXST Rxsight, Inc. | ▲ | $188M |
| LUCY Innovative Eyewear Inc | ▲ | $7M |
Fintel reports that on October 7, 2026, Barclays initiated coverage of Cooper Companies (BMV:COO) with a Equal-Weight recommendation. The Cooper Companies, Inc., based in the United States, operates ...
The average one-year price target for Cooper Companies (BMV:COO) has been revised to MX$1,180.28 / share. This is a decrease of 17.87% from the prior estimate of MX$1,437.11 dated September 13, 2026.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Our AI ranks Cooper Companies, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
A per-ticker accuracy statistic for COO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Cooper Companies, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
8 issuers in our coverage, COO included, share the SEC industry code Ophthalmic Goods. The largest are: Alcon Inc (ALC), Bausch & Lomb Corp (BLCO), Warby Parker Inc. (WRBY), National Vision Holdings, Inc. (EYE), Staar Surgical Co (STAA), Rxsight, Inc. (RXST).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.